REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Oncologico Santafe Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Centro Oncologico Santafe Sas Profile Updated: May 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Centro Oncologico Santafe Sas is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Ambulatory Health Care Services industry. Centro Oncologico Santafe Sas was incorporated on December 06, 2017. There are currently 16 (2025) people employed by Centro Oncologico Santafe Sas. There was a net sales revenue increase of 24798.86% reported in Centro Oncologico Santafe Sas’s latest financial highlights for 2024. During that time, Centro Oncologico Santafe Sas’s total assets grew by 138.43%. In 2024, Centro Oncologico Santafe Sas’s net profit margin decreased by 38.08%.

Headquarters
Ac 127 # 15 A 55
Bogota D.C.; Bogota D.C; Postal Code: 1013

Contact Details: Purchase the Centro Oncologico Santafe Sas report to view the information.

Basic Information
Total Employees:
Purchase the Centro Oncologico Santafe Sas report to view the information.
Financial Auditors:
Purchase the Centro Oncologico Santafe Sas report to view the information.
Incorporation Date:
December 06, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro Oncologico Santafe Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
24798.86%
Total operating revenue
24798.86%
Operating profit (EBIT)
14518.84%
Net Profit (Loss) for the Period
9683.42%
Total Assets
138.43%
Total Equity
368.89%
Operating Profit Margin (ROS)
-25.9%
Net Profit Margin
-38.08%
Return on Equity (ROE)
67.22%
Quick Ratio
-283%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?